|
[1]
|
Li, S., Young, K.H. and Medeiros, L.J. (2018) Diffuse Large B-Cell Lymphoma. Pathology, 50, 74-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jamil, M.O. and Mehta, A. (2016) Diffuse Large B-Cell Lym-phoma: Prognostic Markers and Their Impact on Therapy. Expert Review of Hematology, 9, 471-477. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Cunningham, D., Hawkes, E.A., Jack, A., et al. (2013) Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Patients with Newly Diagnosed Dif-fuse Large B-Cell Non-Hodgkin Lymphoma: A Phase 3 Comparison of Dose Intensification with 14-Day versus 21-Day Cycles. Lancet, 381, 1817-1826. [Google Scholar] [CrossRef]
|
|
[4]
|
Iwahori, K., Shintani, Y., Funaki, S., et al. (2019) Peripher-al T Cell Cytotoxicity Predicts T Cell Function in the Tumor Microenvironment. Scientific Reports, 9, Article No. 2636. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
杨迪, 苏丽萍. 外周血淋巴细胞/单核细胞比值(LMR)及其与乳酸脱氢酶比值对弥漫大B细胞淋巴瘤患者预后的影响[J]. 中国实验血液学杂志, 2020, 28(5): 1563-1569.
|
|
[6]
|
Mohsen, A., Taalab, M., Abousamra, N. and Mabed, M. (2020) Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma. Clinical Lymphoma, Myeloma and Leukemia, 20, e606-e615. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Sawa-Wejksza, K. and Kandefer-Szerszeń, M. (2018) Tu-mor-Associated Macrophages as Target for Antitumor Therapy. Archivum Immunologiae et Therapiae Experimentalis (Warsz), 66, 97-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
刘琦, 郭鹏, 詹文华. LMR和LMR/LDH对原发韦氏环弥漫大B 细胞淋巴瘤预后的影响[J]. 肿瘤防治研究, 2022, 49(2): 110-115.
|
|
[9]
|
黄鑫, 岑洪. 外周血炎症指标与弥漫大B细胞淋巴瘤预后关系的研究进展[J]. 中国癌症防治杂志, 2019, 11(6): 536-540.
|
|
[10]
|
Rusak, M., Bołkun, Ł., Chociej-Stypułkowska, J., Pawlus, J., Kłoczko, J. and Dąbrowska, M. (2016) Flow-Cytometry- Based Evaluation of Pe-ripheral Blood Lymphocytes in Prognostication of Newly Diagnosed DLBCL Patients. Blood Cells, Molecules, and Diseases, 59, 92-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
蔡春颖, 孙丽霞, 吕鸿雁. 初诊时非霍奇金淋巴瘤患者外周血淋巴细胞与单核细胞比值在预后评估中的作用[J]. 临床荟萃, 2016, 31(7): 736-740.
|
|
[12]
|
Bento, L., Díaz-López, A., Barranco, G., et al. (2020) New Prognosis Score Including Absolute Lym-phocyte/Monocyte Ratio, Red Blood Cell Distribution Width and Beta-2 Microglobulin in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO). British Journal of Haematology, 188, 888-897. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhou, S., Xu, L., Ma, Y., et al. (2017) Pe-ripheral Blood Lymphocyte to Monocyte Ratio Recovery from Low Levels at Diagnosis after Completion of First Line Therapy Predicts Good Clinical Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Oncotarget, 8, 19556-19565. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Belotti, A., Doni, E., Bolis, S., et al. (2015) Periph-eral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lym-phoma Patients in the Rituximab Era. Clinical Lymphoma, Myeloma and Leukemia, 15, 208-213. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Porrata, L.F., Ristow, K.M., Habermann, T.M., et al. (2014) Pe-ripheral Blood Absolute Lymphocyte/Monocyte Ratio during Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone Treatment Cycles Predicts Clinical Outcomes in Diffuse Large B-Cell Lymphoma. Leukemia & Lym-phoma, 55, 2728-2738. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Grey, H.M., Kubo, R.T., Colon, S.M., et al. (1973) The Small Subunit of HL-A Antigens Is Beta 2-Microglobulin. Journal of Experimental Medicine, 138, 1608-1612. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Peterson, P.A., Cunningham, B.A., Berggård, I. and Edelman, G.M. (1972) 2-Microglobulin—A Free Immunoglobulin Domain. Proceedings of the National Academy of Sciences of the United States of America, 69, 1697-1701. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Shi, C., Zhu, Y., Su, Y., Chung, L.W. and Cheng, T. (2009) Be-ta2-Microglobulin: Emerging as a Promising Cancer Therapeutic Target. Drug Discovery Today, 14, 25-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Muñana, K.R., Saito, M. and Hoshi, F. (2007) Be-ta-2-Microglobulin Levels in the Cerebrospinal Fluid of Normal Dogs and Dogs with Neurological Disease. Veterinary Clinical Pathology, 36, 173-178. [Google Scholar] [CrossRef]
|
|
[20]
|
Svatoňová, J., Bořecká, K., Adam, P. and Lánská, V. (2014) Beta2-Microglobulin as a Diagnostic Marker in Cerebrospinal Fluid: A Follow-Up Study. Disease Markers, 2014, Article ID: 495402. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Huang, W.C., Wu, D., Xie, Z., et al. (2006) Beta2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis. Cancer Research, 66, 9108-9116.
|
|
[22]
|
Berggård, I. and Bearn, A.G. (1968) Isolation and Properties of a Low Molecular Weight Beta-2-Globulin Occurring in Human Biological Fluids. Journal of Biological Chemistry, 243, 4095-4103. [Google Scholar] [CrossRef]
|
|
[23]
|
Kanemasa, Y., Shimoyama, T., Sasaki, Y., et al. (2017) Be-ta-2 Microglobulin as a Significant Prognostic Factor and a New Risk Model for Patients with Diffuse Large B-Cell Lymphoma. Hematological Oncology, 35, 440-446. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Federico, M., Bellei, M., Marcheselli, L., et al. (2009) Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Fol-licular Lymphoma Prognostic Factor Project. Journal of Clinical Oncology, 27, 4555-4562. [Google Scholar] [CrossRef]
|
|
[25]
|
Chen, Y., Neelapu, S., Feng, L., et al. (2016) Prognostic Signifi-cance of Baseline Peripheral Absolute Neutrophil, Monocyte and Serum β2-Microglobulin Level in Patients with Diffuse Large B-Cell Lymphoma: A New Prognostic Model. British Journal of Haematology, 175, 290-299. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wu, S., Zhou, Y., Hua, H.Y., et al. (2018) Inflammation Marker ESR Is Effective in Predicting Outcome of Diffuse Large B-Cell Lymphoma. BMC Cancer, 18, Article No. 997. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Strojnik, T., Smigoc, T. and Lah, T.T. (2014) Prognostic Value of Erythrocyte Sedimentation Rate and C-Reactive Protein in the Blood of Patients with Glioma. Anticancer Research, 34, 339-347.
|
|
[28]
|
章尤权, 沈冬祎, 吕嘉婧, 等. 弥漫大B细胞淋巴瘤患者血浆红细胞沉降率与预后的相关性研究[J]. 福建医药杂志, 2021, 43(6): 21-25.
|
|
[29]
|
Go, D.J., Lee, E.Y., Lee, E.B., Song, Y.W., Konig, M.F. and Park, J.K. (2016) Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyo-sitis: A Korean Retrospective Cohort Study. Journal of Korean Medical Science, 31, 389-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Rotaru, I., Găman, G.D., Stănescu, C. and Găman, A.M. (2014) Evaluation of Parameters with Potential Prognosis Impact in Patients with Primary Gastric Diffuse Large B-Cell Lym-phoma (PG-DLBCL). Romanian Journal of Morphology and Embryology, 55, 15-21.
|
|
[31]
|
Salvagno, G.L., Sanchis-Gomar, F., Picanza, A. and Lippi, G. (2015) Red Blood Cell Distribution Width: A Simple Parameter with Mul-tiple Clinical Applications. Critical Reviews in Clinical Laboratory Sciences, 52, 86-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Förhécz, Z., Gombos, T., Borgulya, G., Pozsonyi, Z., Prohá-szka, Z. and Jánoskuti, L. (2009) Red Cell Distribution Width in Heart Failure: Prediction of Clinical Events and Rela-tionship with Markers of Ineffective Erythropoiesis, Inflammation, Renal Function, and Nutritional State. American Heart Journal, 158, 659-666. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Lippi, G., Targher, G., Montagnana, M., Salvagno, G.L., Zoppini, G. and Guidi, G.C. (2009) Relation between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients. Archives of Pathology & Laboratory Medicine, 133, 628-632. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Nemeth, E. and Ganz, T. (2014) Anemia of Inflammation. Hematolo-gy/Oncology Clinics of North America, 28, 671-681. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Singh, R., Mishra, M.K. and Aggarwal, H. (2017) Inflammation, Immunity, and Cancer. Mediators of Inflammation, 2017, Article ID: 6027305. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Goyal, H., Gupta, S. and Singla, U. (2016) Level of Red Cell Dis-tribution Width Is Affected by Various Factors. Clinical Chemistry and Laboratory Medicine, 54, e387. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Qin, Y.Y., Wu, Y.Y., Xian, X.Y., et al. (2018) Single and Combined Use of Red Cell Distribution Width, Mean Platelet Volume, and Cancer Antigen 125 for Differential Diagnosis of Ovar-ian Cancer and Benign Ovarian Tumors. Journal of Ovarian Research, 11, 10. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Cheng, S., Han, F., Wang, Y., et al. (2017) The Red Distribution Width and the Platelet Distribution Width as Prognostic Predictors in Gastric Cancer. BMC Gastroenterology, 17, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Sun, P., Zhang, F., Chen, C., et al. (2016) The Ratio of Hemo-globin to Red Cell Distribution Width as a Novel Prognostic Parameter in Esophageal Squamous Cell Carcinoma: A Ret-rospective Study from Southern China. Oncotarget, 7, 42650-42660. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Han, F., Shang, X., Wan, F., et al. (2018) Clinical Value of the Preoperative Neutrophil-to-Lymphocyte Ratio and Red Blood Cell Distribution Width in Patients with Colorectal Carci-noma. Oncology Letters, 15, 3339-3349. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Howell, J., Pinato, D.J., Ramaswami, R., et al. (2017) Integration of the Cancer-Related Inflammatory Response as a Stratifying Biomarker of Survival in Hepatocellular Carcinoma Treated with Sorafenib. Oncotarget, 8, 36161-36170. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Ichinose, J., Murakawa, T., Kawashima, M., et al. (2016) Prog-nostic Significance of Red Cell Distribution Width in Elderly Patients Undergoing Resection for Non-Small Cell Lung Cancer. Journal of Thoracic Disease, 8, 3658-3666. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Wang, J., Xie, X., Cheng, F., et al. (2017) Evaluation of Pretreatment Red Cell Distribution Width in Patients with Multiple Myeloma. Cancer Biomarkers, 20, 267-272. [Google Scholar] [CrossRef]
|
|
[45]
|
Zhou, S., Fang, F., Chen, H., et al. (2017) Prognostic Significance of the Red Blood Cell Distribution Width in Diffuse Large B-Cell Lymphoma Patients. Oncotarget, 8, 40724-40731. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Periša, V., Zibar, L., Sinčić-Petričević, J., Knezović, A., Periša, I. and Barbić, J. (2015) Red Blood Cell Distribution Width as a Simple Negative Prognostic Factor in Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Study. Croatian Medical Journal, 56, 334-343. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Li, M., Xia, H., Zheng, H., et al. (2019) Red Blood Cell Distribution Width and Platelet Counts Are Independent Prognostic Factors and Improve The Predictive Ability of IPI Score in Dif-fuse Large B-Cell Lymphoma Patients. BMC Cancer, 19, Article No. 1084. [Google Scholar] [CrossRef] [PubMed]
|